Manoira Corporation

Corvus is the founding and majority shareholder of Manoira Corporation, a specialty animal treatment company focused on developing proprietary intellectual property using solid form technology. Manoira specialise in the research and development of pharmaceutical and other health products for livestock and pets and intend to develop their portfolio of products to prevent and treat a variety of animal diseases and conditions.

Conduit Pharmaceuticals

Corvus is the founding and majority shareholder of Conduit Pharmaceuticals, a disease agnostic life science company providing an efficient model for compound development. Conduit successfully completed a business combination with Murphy Canyon Acquisition Corp. in September 2023 for a proforma enterprise value of approximately $720 MM. (Nasdaq: CDT)

East Imperial Plc

Corvus Capital is pleased to have advised Taylor Partners, the activist shareholder of East Imperial plc (LON: EISB), alongside Strand Hanson, on Taylor Partner's successful proposition to make a number of Board changes at EISB.

Ebers Tech Inc.

Corvus is the founding shareholder of Ebers Tech Inc., a private Canadian pharmaceutical company that utilises Co-crystallization and other technology to generate and monetize unique patented compounds and Intellectual Property around cannabinoids and psychedelics.

Nuformix

Corvus originated and negotiated Nuformix’s successful listing on the London Stock Exchange, by way of a Reverse Takeover by Levrett Plc, delivering 120x return for original investors.

ASOS Plc

Corvus Capital was one of the founding shareholders in ASOS Plc. now the UK’s largest independent online fashion and beauty retailer.

Cloudtag®

Corvus was the founding shareholder & principal provider of capital to AIM listed CloudTag.

Lodore Resources

Corvus was a founding shareholder and structured the initial finance for the flotation of Lodore Resources plc.